Roche's AXELIOS 1 enters next generation DNA sequencing. Can it or rivals unseat Illumina's long-standing market dominance?

With 10 cases in 2025, Guinea worm could be the second disease ever eradicated. Here is what makes disease eradication ...

New therapies in the clinic for bipolar disorder hope to meet unmet needs of efficacy and minimal side effects.

With a major restructuring currently underway, we take a look at Takeda's pipeline strategy – including three planned major ...

June 2026 saw drug development in oncology and neurology continue and biotech deals over small molecules and RNA therapies ...

Europe’s pandemic preparedness capital is creating a rare opening for biotech innovators. Since COVID-19, the next pandemic is no longer abstract, and preparedness is no longer optional. Europe is ...

Human immunodeficiency virus (HIV) research has come a long way since the virus was discovered in the 1980s. Antiretroviral therapy (ART) marked a turning point in HIV treatment, changing the lives of ...

Roohi Mariam Peter has been a journalist at Labiotech since 2023. She writes news articles and in-depth features on healthcare, biopharma, science, fundraising, markets, and emerging therapies. She ...

Biotech associations play a crucial role in advancing the industry by connecting biotech companies, pharmaceutical firms, academic institutions, research organizations, policymakers, and investors.

There was a time when the numbers told an unoptimistic story about Roche. Its three oncology blockbusters, Herceptin, Avastin, and Rituxan, had built it into the world’s largest cancer drug maker, ...

So far, the visible strategy around bronchiectasis has been managing the problems it creates — mucus retention, repeated infections, airway inflammation, and exacerbations. Airway clearance, ...